ALB and Ascites: Thus, its biological activity even increased in vivo[14], [18] Preclinical and clinical trials have confirmed the safety and efficacy of using a recombinant HSA (rHSA) preparation for different disease conditions, such as hemorrhagic shock, cirrhosis with ascites, and other critical clinical conditions related to plasma volume and oncotic pressure.